How common is human toxocariasis? Towards standardizing our knowledge

Huw Smith, Celia Holland, Mervyn Taylor, J-F. Magnaval, Peter Schantz, Rick Maizels

Research output: Contribution to journalLiterature reviewpeer-review

Abstract / Description of output

Our understanding of the global impact and cost of human toxocariasis is poor because there is insufficient clinical awareness and no clear repository for the efficacy of clinical, laboratory and treatment interventions. Uniform clinical and laboratory investigative approaches maximize disease diagnosis. International collaboration is required to develop web-based, professional educational support, surveillance questionnaires and standardized serodiagnostic criteria. Determining clinical benefits and treatment outcomes using less crossreactive antigens will enhance clinical and treatment interventions. Increased liaison will identify realistic occurrence and prevalence data and cost benefits of intervention. Web-based centres of excellence and repositories of current knowledge, which augment current veterinary and public health educational sites, should be supported. Expected outcomes should be capable of addressing the clinical and financial burdens of this treatable disease.

Original languageEnglish
Pages (from-to)182-188
Number of pages7
JournalTrends in Parasitology
Volume25
Issue number4
Early online date6 Mar 2009
DOIs
Publication statusPublished - 1 Apr 2009

Fingerprint

Dive into the research topics of 'How common is human toxocariasis? Towards standardizing our knowledge'. Together they form a unique fingerprint.

Cite this